Namba et al., 1969 - Google Patents
Effect on mice of intravenous administration of lymphocytes from normal subjects and from patients with myasthenia gravisNamba et al., 1969
- Document ID
- 309029215747789728
- Author
- Namba T
- Arimori S
- Grob D
- Publication year
- Publication venue
- Neurology
External Links
Snippet
MATERIALS AND METHODS Circulating lymphocytes were isolated by the method of Coulson and Chalmersl" from fresh defibrinated blood which was mixed with 3% gelatin in physiological saline solution. Over 90% of the lymphocytes isolated by this method were …
- 210000004698 lymphocyte 0 title abstract description 110
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Storb et al. | Treatment of established human graft-versus-host disease by antithymocyte globulin | |
Dalmasso et al. | Studies on the role of the thymus in immunobiology: Reconstitution of immunologic capacity in mice thymectomized at birth | |
Reisner et al. | Transplantation for severe combined immunodeficiency with HLA-A, B, D, DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells | |
Nicholas et al. | Human blood chimeras | |
Hay et al. | The flow of blood to lymph nodes and its relation to lymphocyte traffic and the immune response. | |
Benjamin et al. | Mechanisms of monoclonal antibody‐facilitated tolerance induction: a possible role for the CD4 (L3T4) and CD11a (LFA‐1) molecules in self‐non‐self discrimination | |
MANNICK et al. | Prolongation of allograft survival by an alpha globulin isolated from normal blood | |
BIELORY et al. | Human serum sickness: a prospective analysis of 35 patients treated with equine anti-thymocyte globulin for bone marrow failure | |
Gorer et al. | Pathological changes in F1 hybrid mice following transplantation of spleen cells from donors of the parental strains | |
Brown et al. | The in vivo behaviour of complement-coated red cells: studies in C6-deficient, C3-depleted and normal rabbits | |
Fudenberg et al. | “Acquired Agammaglobulinemia” with Auto‐Immune Hemolytic Disease: Graft‐versus‐Host Reaction? | |
Shortman et al. | Separation of stages in the development of the" T" cells involved in cell-mediated immunity | |
Hersey et al. | Antibody-dependent, cell-mediated cytotoxicity against melanoma cells induced by plasmapheresis | |
Chiller et al. | Restoration of immunocompetency in tolerant lymphoid cell populations by cellular supplementation | |
Coombs et al. | Haemolytic disease of newborn foals due to iso-immunization of pregnancy | |
Namba et al. | Effect on mice of intravenous administration of lymphocytes from normal subjects and from patients with myasthenia gravis | |
Gottlieb et al. | Allogeneic marrow transplantation after total lymphoid irradiation (TLI): effect of dose/fraction, thymic irradiation, delayed marrow infusion, and presensitization | |
Argyris et al. | Mouse peritoneal cells: Their ability to elicit or produce antibody after exposure to antigen | |
Van Putten et al. | The effect of preceding blood transfusions on the fate of homologous bone marrow grafts in lethally irradiated monkeys | |
Reif et al. | Leukemia L1210 therapy trials with antileukemia serum and Bacillus Calmette-Guérin | |
Dooren et al. | Sex-linked thymic epithelial hypoplasia in two siblings: Attempt at treatment by transplantation with fetal thymus and adult bone marrow | |
Chow et al. | Renal transplant patients treated with total lymphoid irradiation show specific unresponsiveness to donor antigens the mixed leukocyte reaction (MLR). | |
Ball et al. | Biological effects of the neonatal injection of 7, 12-dimethylbenz [a] anthracene | |
Wachtel et al. | The role of passenger leukocytes in the anomalous survival of neonatal skin grafts in mice | |
Warkentin et al. | Successful engraftment of NA1 positive bone marrow in a patient with the neutrophil antibody, anti-NA1 |